Robert Zaczek
Chief Tech/Sci/R&D Officer at NeurOp, Inc.
Profile
Robert Zaczek is currently the Chief Scientific Officer at NeurOp, Inc. He previously worked as the Executive Director of Psychiatry Drug Discovery at Bristol Myers Squibb Co. and as the Vice President at DuPont Pharmaceuticals Co. Zaczek earned a doctorate degree from The Johns Hopkins University School of Medicine.
Robert Zaczek active positions
| Companies | Position | Start |
|---|---|---|
NeurOp, Inc.
 NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Former positions of Robert Zaczek
| Companies | Position | End |
|---|---|---|
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Robert Zaczek
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
NeurOp, Inc.
NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Robert Zaczek
